Legal & General Group Plc

Position in GALT — Galectin Therapeutics Inc

CIK 764068 London, X0

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,631

+$21,585 QoQ

Shares Held

4,662

+12168.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#81

of 98 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. GALT ranks #237 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,631	4,662	+12168.4%	Shares	Defined	2026-08-14
2025-03-31	$46	38	-98.5%	Shares	Defined	2025-05-15
2024-12-31	$3,201	2,482	0.0%	Shares	Defined	2025-02-13
2024-09-30	$6,825	2,482	0.0%	Shares	Defined	2025-02-28
2024-06-30	$5,609	2,482	-45.5%	Shares	Defined	2025-05-29
2021-03-31	$9,877	4,552	0.0%	Shares	Defined	2021-05-17
2020-12-31	$10,196	4,552	0.0%	Shares	Defined	2021-02-12
2020-09-30	$12,153	4,552	-30.4%	Shares	Defined	2020-11-13
2020-06-30	$20,012	6,540	-4.9%	Shares	Defined	2020-08-14
2020-03-31	$13,480	6,878	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.